Treatment decisions are based on tumor size and grade, degree of nodal of involvement, evidence of metastasis, expression of the estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) in tumors, and the age and health of the patients. The gene discussed is ERBB2; the disease is neoplasm.